Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Hip
Phase 2
4,000
about 11 years
18–90
1 site in PA
Why this study is shown
What this study is about
Researchers are testing a treatment called StroMed plus platelet rich plasma (PRP) for pain and inflammation in people with hip osteoarthritis. The trial will follow 50 patients initially, with plans to expand to include 4,000 more participants over 4049 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive [StroMed + platelet rich plasma (PRP)]
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Change is being assessed by MRI of afflicted joint, Change is being assessed for the NRS survey (Numerical Rating Scale for Pain), Change is being assessed for the SF36 survey (Short Form Quality of Life Survey)
Musculoskeletal